PROPANC BIOPHARMA, INC. Operating Lease Right-of-Use Assets
PROPANC BIOPHARMA, INC. (PPCB) had Operating Lease Right-of-Use Assets of $46.58 thousand as of 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-17
- 2026-03-31: Operating Lease, Right-of-Use Asset $46.58K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $50.90K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $56.28K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $59.41K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-03-31 | $46.58K S-1 · filed 2026-07-17 |
| 2025-12-31 | $50.90K S-1 · filed 2026-04-10 |
| 2025-09-30 | $56.28K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $59.41K S-1 · filed 2026-07-17 |
| 2025-05-04 | $62.13K S-1 · filed 2026-07-17 |
| 2024-06-30 | $17.80K S-1 · filed 2026-07-17 |
| 2023-03-31 | $44.52K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $50.67K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $53.02K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $62.52K 10-Q · filed 2023-05-15 |
| 2022-05-04 | $66.20K S-1 · filed 2026-07-17 |
| 2021-03-31 | $2.40K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $9.70K 10-Q · filed 2021-02-12 |
| 2020-09-30 | $15.79K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $21.68K 10-K · filed 2021-09-28 |
| 2020-03-31 | $24.96K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $35.39K 10-Q · filed 2020-02-14 |
| 2019-09-30 | $40.33K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |